Well-recognized risk factors for zygomycosis include diabetic ketoacidosis, immunocompromise, and deferoxamine therapy for iron or aluminum overload, usually in patients undergoing kidney dialysis. We report a case of fatal nasal-orbital-cerebral zygomycosis in an 82-year-old man with known myelodysplasia and well-controlled diabetes. He was not receiving deferoxamine. Despite radical surgery and amphotericin B therapy, he died; primary hemochromatosis with gross iron overload was found post mortem. Experimental evidence suggests iron overload without deferoxamine therapy may be a risk factor for zygomycosis; the findings in this case would support this hypothesis.
McNab AA, McKelvie P. Iron Overload Is a Risk Factor for Zygomycosis. Arch Ophthalmol. 1997;115(7):919–921. doi:10.1001/archopht.1997.01100160089018
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: